Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease.
作者信息
Sheshadri Ajay, Huang Howard J, Bashoura Lara, Alousi Amin M, Alkhunaizi Mansour, Sharifi Husham, Hsu Joe L
机构信息
Department of Pulmonary Medicine, MD Anderson Cancer Center, The University of Texas, Houston, TX.
Division of Pulmonary, Critical Care and Sleep Medicine, Houston Methodist Hospital, Houston, TX.
出版信息
Blood Adv. 2022 Sep 13;6(17):4984-4986. doi: 10.1182/bloodadvances.2022008201.
Abstract
摘要
相似文献
1
Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease.移植物抗宿主病可能导致肺部受限，但并非所有的受限都是移植物抗宿主病。
Blood Adv. 2022 Sep 13;6(17):4984-4986. doi: 10.1182/bloodadvances.2022008201.
2
Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.异基因造血干细胞移植后的移植物抗宿主效应：移植物抗宿主病和移植物抗白血病效应
Curr Opin Immunol. 1996 Oct;8(5):674-80. doi: 10.1016/s0952-7915(96)80085-9.
3
A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease.肺慢性移植物抗宿主病的表型分类起点。
Blood Adv. 2022 Sep 13;6(17):4987-4988. doi: 10.1182/bloodadvances.2022008394.
4
Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.在成人中，以骨髓作为干细胞来源可改善无移植物抗宿主病、无复发的生存率。
Haematologica. 2016 Jun;101(6):764-72. doi: 10.3324/haematol.2015.138990. Epub 2016 Apr 1.
5
Ocular graft vs. host disease after hematopoietic stem cell transplantation.造血干细胞移植后的眼部移植物抗宿主病
Insight. 2013 Winter;38(1):11-8.
6
Oral submucous fibrosis induced by graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后移植物抗宿主病引起的口腔黏膜下纤维性变。
Oral Oncol. 2022 Jul;130:105919. doi: 10.1016/j.oraloncology.2022.105919. Epub 2022 May 17.
7
Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.异基因干细胞移植患者放疗后发生移植物抗宿主病：两例报告
J Med Case Rep. 2016 Jul 28;10:209. doi: 10.1186/s13256-016-0999-z.
8
Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.基因和临床因素均能预测异基因造血干细胞移植后移植物抗宿主病的发生。
Transplantation. 2001 Aug 27;72(4):699-706. doi: 10.1097/00007890-200108270-00024.
9
Leflunomide for chronic musculoskeletal graft versus host disease following allogeneic hematopoietic stem cell transplant.来氟米特用于异基因造血干细胞移植后慢性肌肉骨骼移植物抗宿主病
Bone Marrow Transplant. 2020 Feb;55(2):467-469. doi: 10.1038/s41409-019-0545-x. Epub 2019 May 14.
10
Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease.来自无关供体的外周血干细胞移植且无严重移植物抗宿主病。
Bone Marrow Transplant. 1995 Dec;16(6):856-7.
引用本文的文献
1
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens.采用清髓性预处理方案进行异基因造血细胞移植后闭塞性细支气管炎综合征风险的评估。
Bone Marrow Transplant. 2024 Dec;59(12):1744-1753. doi: 10.1038/s41409-024-02422-z. Epub 2024 Sep 27.
2
A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease.肺慢性移植物抗宿主病的表型分类起点。
Blood Adv. 2022 Sep 13;6(17):4987-4988. doi: 10.1182/bloodadvances.2022008394.
本文引用的文献
1
The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease.ISHLT 慢性肺移植物功能障碍共识标准适用于肺慢性移植物抗宿主病。
Blood Adv. 2022 Jul 26;6(14):4196-4207. doi: 10.1182/bloodadvances.2021006885.
2
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.美国国立卫生研究院慢性移植物抗宿主病临床试验标准共识开发项目：四、2020 年高度病态形式报告。
Transplant Cell Ther. 2021 Oct;27(10):817-835. doi: 10.1016/j.jtct.2021.06.001. Epub 2021 Jun 10.
3
Chronic Lung Allograft Dysfunction: Review of CT and Pathologic Findings.慢性肺移植功能障碍：CT与病理表现综述
Radiol Cardiothorac Imaging. 2021 Feb 11;3(1):e200314. doi: 10.1148/ryct.2021200314. eCollection 2021 Feb.
4
Incidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation.异基因造血细胞移植后特发性肺炎综合征的发病率、危险因素及预后
Biol Blood Marrow Transplant. 2020 Feb;26(2):413-420. doi: 10.1016/j.bbmt.2019.09.034. Epub 2019 Oct 9.
5
Cause of pleuroparenchymal fibroelastosis following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后胸膜实质纤维弹性组织增生症的病因
Respir Investig. 2019 Jul;57(4):321-324. doi: 10.1016/j.resinv.2019.04.003. Epub 2019 May 9.
6
Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT.慢性肺移植功能障碍：定义、诊断标准及治疗方法——国际心肺移植学会肺委员会共识报告
J Heart Lung Transplant. 2019 May;38(5):493-503. doi: 10.1016/j.healun.2019.03.009. Epub 2019 Apr 3.
7
Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients.呼吸道病毒感染后肺部损伤与异基因造血细胞移植受者的高死亡率相关。
Biol Blood Marrow Transplant. 2019 Apr;25(4):800-809. doi: 10.1016/j.bbmt.2018.11.022. Epub 2018 Dec 3.
8
Lung histopathology of non-infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation.异基因造血干细胞移植后非感染性肺部并发症的肺组织病理学。
Histopathology. 2018 Nov;73(5):832-842. doi: 10.1111/his.13697. Epub 2018 Aug 19.
9
Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation.异基因造血干细胞移植后的非感染性肺部并发症。
Eur Respir J. 2018 May 3;51(5). doi: 10.1183/13993003.02617-2017. Print 2018 May.
10
Pretransplant chest computed tomography screening in asymptomatic patients with leukemia and myelodysplastic syndrome.白血病和骨髓增生异常综合征无症状患者的移植前胸部计算机断层扫描筛查
Bone Marrow Transplant. 2017 Mar;52(3):476-479. doi: 10.1038/bmt.2016.309. Epub 2016 Dec 12.
Zotero 插件